DNDi began working in Japan in 2004, by establishing projects and providing support to developing discovery projects, in better positioning DNDi within the country, as well as with fundraising activities. Based in Tokyo, DNDi Japan is strengthening its presence in the country by expanding its relationships with academia, pharmaceutical companies, government, and media.
Projects
- CpG-D35 for CL
- DNDI-6174
- DNDI-8526 (S07 series)
- Fosravuconazole
- Mitsubishi-Tanabe Hit-to-lead for Chagas and leishmaniasis
- New benznidazole regimens
- NTD Drug Discovery Booster Hit-to-lead
- Screening Chagas disease and leishmaniasis
- Series-5824 (MT)
DNDi Japan
3F Parkwest Bldg
6-12-1 Nishi-Shinjuku
Shinjuku-ku
Tokyo 160-0023
Japan
Tel: +81 3 6258 0303
Fax: +81 3 5937 6977
